Product Images Lescol XL

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Lescol XL NDC 0078-0354 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Sandoz logo - lescol 01

Sandoz logo - lescol 01

Fluvastatin sodium structural formula - lescol 02

Fluvastatin sodium structural formula - lescol 02

Figure 1. Primary Endpoint – Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population) - lescol 03

Figure 1.	Primary Endpoint – Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population) - lescol 03

Figure 2. Lescol® Intervention Prevention Study - Primary and Secondary Endpoints - lescol 04

Figure 2.	Lescol® Intervention Prevention Study - Primary and Secondary Endpoints - lescol 04

Figure 3 Change in Minimum Lumen Diameter (mm) - lescol 05

Figure 3 Change in Minimum Lumen Diameter (mm) - lescol 05

Figure 4 Change in % Diameter Stenosis - lescol 06

Figure 4 Change in % Diameter Stenosis - lescol 06

This text describes a chart showing a scale from 0 to 400%, with percentages in 50% increments, representing a change in diameter stenosis. The chart also includes two groups, one that received Monotherapy and another that received Combination Therapy. The abbreviations' meaning "CME" is defined as cholestyramine.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.